|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.48 EUR | 0.00% |
|
-0.99% | -23.78% |
| 06-09 | Buy-side pressure on MIB; Unipol and BPER lead gains | AN |
| 06-08 | Clínica Baviera, the copy-paste machine |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 158M | 179M | 155M | 145M | 91.33M | |||||
Depreciation & Amortization - CF | 143M | 160M | 174M | 193M | 206M | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 74.71M | 80.08M | 55.43M | 59.84M | 61.09M | |||||
Depreciation & Amortization, Total | 218M | 240M | 229M | 253M | 267M | |||||
Amortization of Deferred Charges, Total - (CF) | - | - | 38.02M | 48.23M | 44.73M | |||||
(Gain) Loss From Sale Of Asset | - | - | - | - | - | |||||
Asset Writedown & Restructuring Costs | 9.6M | 334K | 506K | 2.92M | 3.6M | |||||
(Income) Loss On Equity Investments - (CF) | -120K | -306K | -550K | -221K | -224K | |||||
Stock-Based Compensation (CF) | - | - | - | - | - | |||||
Net Cash From Discontinued Operations | - | - | - | - | -308K | |||||
Other Operating Activities, Total | 9.19M | 36.74M | 11.03M | 4.93M | 14.89M | |||||
Change In Accounts Receivable | 3.02M | -22.51M | -49.12M | 3.13M | -1.67M | |||||
Change In Inventories | 178K | -16.21M | -11.36M | -2.46M | 2.59M | |||||
Change In Accounts Payable | 53.09M | 80.24M | 24.15M | 6.68M | -5.4M | |||||
Change in Other Net Operating Assets | 11.82M | -37.9M | 16.62M | -10.55M | -1.83M | |||||
Cash from Operations | 462M | 459M | 414M | 451M | 414M | |||||
Capital Expenditure | -51.77M | -56.85M | -75.34M | -84.97M | -56.39M | |||||
Sale of Property, Plant, and Equipment | 2.37M | 9.34M | 1.8M | 1.39M | 1.68M | |||||
Cash Acquisitions | -428M | -87.49M | -122M | -190M | -70.26M | |||||
Sale (Purchase) of Intangible assets | -61.63M | -58.79M | -66.31M | -61.45M | -62.02M | |||||
Investment in Marketable and Equity Securities, Total | 5.17M | - | - | - | - | |||||
Other Investing Activities, Total | - | - | - | - | - | |||||
Cash from Investing | -534M | -194M | -261M | -335M | -187M | |||||
Long-Term Debt Issued, Total | 7.89M | - | - | 199M | 109M | |||||
Total Debt Issued | 7.89M | - | - | 199M | 109M | |||||
Long-Term Debt Repaid, Total | -95.22M | -236M | -116M | -129M | -137M | |||||
Total Debt Repaid | -95.22M | -236M | -116M | -129M | -137M | |||||
Issuance of Common Stock | 458K | - | - | - | - | |||||
Repurchase of Common Stock | -31.08M | -53.09M | - | -25.4M | -108M | |||||
Common Dividends Paid | -49.36M | -58.24M | -65.36M | -65.59M | -65.3M | |||||
Common & Preferred Stock Dividends Paid | -49.36M | -58.24M | -65.36M | -65.59M | -65.3M | |||||
Other Financing Activities, Total | -41.33M | -6.84M | 46.51M | 2.52M | -909K | |||||
Cash from Financing | -209M | -354M | -135M | -18.85M | -202M | |||||
Foreign Exchange Rate Adjustments | 3.4M | 68K | -3.51M | -1.52M | -5.19M | |||||
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | |||||
Net Change in Cash | -276M | -88.89M | 13.49M | 95.69M | 20.05M | |||||
Supplemental Items | ||||||||||
Cash Income Tax Paid (Refund) | 65.58M | 44.86M | 77.68M | 68.93M | 44.7M | |||||
Levered Free Cash Flow | 314M | 338M | 321M | 310M | 295M | |||||
Unlevered Free Cash Flow | 331M | 357M | 349M | 346M | 333M | |||||
Change In Net Working Capital | -43.71M | -41.74M | -21.56M | -8.39M | 8.9M | |||||
Net Debt Issued / Repaid | -87.33M | -236M | -116M | 69.62M | -27.82M |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















